GN Store Nord A/S (CPH:GN)
91.90
-6.10 (-6.22%)
At close: Mar 19, 2026
GN Store Nord Market Cap
GN Store Nord has a market cap or net worth of 14.27 billion as of March 19, 2026. Its market cap has decreased by -23.14% in one year.
Market Cap
14.27B
Enterprise Value
23.97B
Revenue
16.78B
Ranking
n/a
PE Ratio
21.88
Stock Price
91.90
Market Cap Chart
Since March 30, 1993, GN Store Nord's market cap has increased from 330.14M to 14.27B, an increase of 4,222.35%. That is a compound annual growth rate of 12.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 14.27B | -8.20% |
| Dec 30, 2025 | 15.54B | -20.19% |
| Dec 30, 2024 | 19.48B | -22.12% |
| Dec 29, 2023 | 25.01B | 22.33% |
| Dec 30, 2022 | 20.44B | -61.08% |
| Dec 30, 2021 | 52.52B | -16.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.10T |
| Genmab | 104.68B |
| Coloplast | 100.74B |
| ALK-Abelló | 46.40B |
| H. Lundbeck | 36.60B |
| Ambu A/S | 19.06B |
| Zealand Pharma | 18.94B |
| Bavarian Nordic | 14.21B |